Common Contracts
1 similar Global License Agreement contracts
Sign a Global License Agreement for OCH-NCNP1Global License Agreement • September 5th, 2019
EA Pharma Co., Ltd. (President, Yuji Matsue; Headquarters, Tokyo, Japan) (hereinafter “EA Pharma”) and National Center of Neurology and Psychiatry (President, Hidehiro Mizusawa; Headquarters, Tokyo, Japan) (hereinafter “NCNP”) have signed a worldwide exclusive license agreement for development, manufacture and marketing for all indications of OCH-NCNP1, which is under development by NCNP (hereinafter “OCH”).
